Blog7 min

Pipeline health and revenue growth: what actually connects them

Pipeline size barely predicts revenue growth. Pipeline shape does. Four things connect: how new the pipeline is, how evenly value is spread across deals, how reliably deals close in the month they were forecast for, and whether coverage is rising or falling. Only the last is about size, and it is the weakest of the four.

Why coverage ratio disappoints

Coverage — gross open pipeline divided by target — is the standard health metric and it has a structural flaw: it increases both when you add good deals and when you fail to close bad ones. A team whose coverage climbed from 3× to 4× might have had a strong generation quarter or might simply have stopped marking deals lost. The number cannot tell you which.

It is still worth tracking, as a trend rather than a level, and in combination with age. Coverage rising while average deal age also rises is not health; it is accumulation.

Any metric that goes up for both good and bad reasons cannot be read on its own. Coverage needs a second number beside it before it means anything.

The four that connect to revenue

1. Pipeline age, as a distribution. What share of open value entered the pipeline in the last 60 days? A healthy pipeline is constantly refreshed. One where most value is older than two sales cycles is a pipeline that has stopped converting and started collecting, and it will produce a revenue drop one cycle later.

2. Concentration. What share of the quarter sits in the top three deals? High concentration is not unhealthy in itself — plenty of good businesses are lumpy — but it changes what the number means. A quarter resting on two deals is a bet, and should be reported as one rather than as a forecast.

3. Slippage rate. Of the deals forecast to close this month, what share actually did? This is the single best leading indicator of a revenue problem, because deals start moving before they start dying. It turns before win rate does, usually by a full cycle.

4. Generation against consumption. New qualified pipeline created this month versus pipeline removed — won, lost, or written off. Sustained negative means next quarter is already smaller than this one, whatever today's coverage ratio says.

How these turn into growth, or do not

Revenue growth needs two things at once: enough pipeline, and a conversion process that holds up as volume rises. Teams usually have a problem with exactly one of them, and the diagnosis is straightforward.

  • Coverage healthy, slippage rising: a conversion problem. More pipeline will not fix it and will mask it for a quarter.
  • Coverage falling, slippage stable: a generation problem. The sales motion works; there is not enough going into it.
  • Both deteriorating: usually market conditions rather than execution, and worth checking cycle length before reorganising anything.
  • Both healthy, revenue flat: look at deal size and segment. You are converting fine and selling to the wrong people, or at the wrong price.

Making it a monthly habit

Four numbers, recorded monthly, each with last month's beside it. It takes ten minutes and it is more informative than most pipeline dashboards, because every one of them is about a direction rather than a level.

The part that compounds is the record. Any of these numbers in isolation is close to meaningless; six months of them tells you whether what you changed in March worked, which is a question most sales organisations cannot answer about anything they did.

All articles